Antibody Library Technologies Market - insightSLICE

Antibody Library Technologies Market - insightSLICE

Antibody Library Technologies Market Global Sales are Expected to Reach US$ 252.9 Million by 2032

SANTA ROSA, CALIFORNIA, USA, April 26, 2023/EINPresswire.com/ -- The Global Antibody Library Technologies Market Share, Trends, Analysis and Forecasts, 2023-2032 offers detailed insights into the emerging trends, drivers, opportunities, and challenges impacting the global antibody library technologies market. It also provides a thorough analysis of market segments, including products, applications, and competition.

The global antibody library technologies market was estimated to be US$ 169.22 Million in 2022 and is expected to reach US$ 252.9 Million by 2032 at a CAGR of 4.1%. Antibody library technology is a technique used to generate large numbers of antibodies with diverse specificities. The process involves the creation of a collection, or library, of antibodies that can be screened for binding to a specific target molecule or antigen. This allows researchers to identify and select the best antibodies for use in a variety of applications, including diagnostic testing and therapeutic treatments.

Antibody libraries can be generated using a variety of methods, including phage display, yeast display, ribosome display, and mammalian cell display. Each method has its advantages and disadvantages, but they all involve the creation of a large library of diverse antibodies that can be screened for specificity and affinity. Antibody library technology has revolutionized the field of antibody research and development, enabling the generation of highly specific and potent antibodies for a wide range of applications.

Get a Sample (PDF file) of this report: https://www.insightslice.com/request-sample/1441

Growth driving factors of Global Antibody Library Technologies Market

Following are some of the major factors driving the market –

Rising demand for targeted therapy: With an increasing prevalence of chronic diseases, the demand for targeted therapy is rising. Targeted therapy focuses on specific molecular targets in the body and helps to reduce side effects associated with traditional treatments. For instance, monoclonal antibodies are a type of targeted therapy that are widely used in the treatment of cancer. They are designed to attach themselves to specific proteins on the surface of cancer cells and help the immune system to recognize and destroy these cells.

Increasing prevalence of chronic diseases: Chronic diseases such as cancer, autoimmune diseases, and infectious diseases are on the rise globally. Antibody library technologies are being widely used for the development of new drugs to treat these diseases. For instance, Roche's drug Herceptin, which is used to treat breast cancer, was developed using antibody library technology.

Advancements in antibody engineering and technologies: Advancements in antibody engineering and technologies are driving the growth of the global antibody library technologies market. The development of technologies such as phage display and yeast display have made it possible to generate a diverse range of antibodies for a variety of applications. For instance, Amgen's drug Repatha, which is used to treat high cholesterol, was developed using phage display technology.

Growing investment in R&D activities: Growing investment in research and development activities is driving the growth of the global antibody library technologies market. Many pharmaceutical and biotechnology companies are investing heavily in R&D activities to develop new drugs and therapies. For instance, Bristol Myers Squibb and AstraZeneca entered into a collaboration to develop and commercialize antibody-based drugs for the treatment of cancer.

The leading market segments of Global Antibody Library Technologies Market

Based on type, phage display technology is one of the most commonly used methods for generating antibody libraries and has been widely adopted in the pharmaceutical and biotechnology industries. This is because phage display technology is relatively simple to use and can generate large libraries of diverse antibodies quickly and efficiently. While phage display is a widely used method, other technologies such as yeast display and mammalian cell display are also gaining popularity due to their ability to generate antibodies with higher affinity and specificity. Nonetheless, phage display remains one of the most popular and effective methods for generating antibody libraries and is expected to continue to dominate the market in the near future.

Request for Custom Research: https://www.insightslice.com/request-customization/1441

Geographically, the global antibody library technologies market is witnessing significant growth, with North America currently leading the market due to the presence of leading pharmaceutical and biotechnology companies. Europe is another significant market, driven by the increasing demand for monoclonal antibodies. The Asia-Pacific region is expected to witness significant growth in the coming years, driven by the increasing prevalence of chronic diseases and investment in research and development activities. The Middle East and Africa region and South America are also expected to witness moderate growth due to the increasing demand for targeted therapies and investment in healthcare infrastructure.

The key players of the Global Antibody Library Technologies Market are:

Abcam (UK), Abnova (Taiwan), Adimab (USA), Affinity Biosciences (China), Creative Biolabs (USA), Genscript Biotech Corporation (China), Ligand Pharmaceuticals (USA), Lonza Group (Switzerland), Merck KGaA (Germany), MorphoSys (Germany), Novartis AG (Switzerland), Roche Holding AG (Switzerland), Thermo Fisher Scientific (USA), Xencor Inc. (USA), Zyagen (USA) and Others.

Market Segmentation

By Type

• Phage Display
• Ribosome Display
• Yeast Display
• Mammalian Cell Display

By Application

• Drug Discovery & Development
• Research
• Other Application

By End User

• Biopharmaceutical Companies
• Academic and Research Institutes
• Other

By Region

• North America
* United States
* Canada
* Rest of North America

• Europe
* Germany
* United Kingdom
* Italy
* France
* Spain
* Rest of Europe

• Asia Pacific
* Japan
* India
* China
* Australia
* South Korea
* Rest of Asia Pacific

• Middle East & Africa
* UAE
* Saudi Arabia
* South Africa
* Rest of the Middle East & Africa

• South America
* Brazil
* Rest of South America

Purchase the complete report: https://www.insightslice.com/buy-now/1441

More Reports:

Saliva Based Testing Screening Market: https://www.insightslice.com/saliva-based-testing-screening-market

Transseptal Access Systems Market: https://www.insightslice.com/transseptal-access-systems-market

Autogenous Vaccines Market: https://www.insightslice.com/autogenous-vaccines-market

Health Coach Market: https://www.insightslice.com/health-coach-market

About us:
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions.

Contact us:

Alex
insightSLICE (Same Page Management Consulting Pvt. Ltd.)
+1 707-736-6633
alex@insightslice.com
Visit us on social media:
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.